Ola Hou Clinic | |
98-084 Kamehameha Highway Suite 306 Alea HI 96701 | |
(808) 487-5433 | |
Not Available |
Full Name | Ola Hou Clinic |
---|---|
Speciality | Counselor - Mental Health |
Location | 98-084 Kamehameha Highway Suite 306, Alea, Hawaii |
Authorized Official Name and Position | George Rhoades (PSYCHOLOGIST) |
Authorized Official Contact | 8085514909 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Ola Hou Clinic 98-084 Kamehameha Highway Suite 306 Alea HI 96701 Ph: (808) 487-5433 | Ola Hou Clinic 98-084 Kamehameha Highway Suite 306 Alea HI 96701 Ph: (808) 487-5433 |
NPI Number | 1831975374 |
---|---|
Provider Enumeration Date | 08/31/2023 |
Last Update Date | 08/31/2023 |
Identifier | Type | State | Issuer |
---|---|---|---|
1831975374 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
News Archive
The Lymphoma Research Foundation (LRF) is pleased to announce that David Frank, MD, PhD of the Dana-Farber Cancer Institute and Thomas Kipps, MD, PhD, Moores Cancer Center, University of California, San Diego are the recipients of the second round of funding under the Foundation's Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Research Initiative.
People living in regions with high levels of outdoor artificial light at night may face a higher risk of developing thyroid cancer.
Procognia is proud to announce that yesterday it signed a binding memorandum of understanding with Euro-Diagnostica (ED), a European diagnostic company that currently operates in the Scandinavian and Benelux markets, and is expected to expand its activity into other markets which may include Germany, Austria, Switzerland, and the UK in the near future.
Daniel H. Solomon, M.D., M.P.H., from Brigham and Women's Hospital, Boston, and Jerry Avorn, M.D., of Harvard University School of Medicine, write in the January 24 issue of Archives of Internal Medicine that the withdrawal of rofecoxib (Vioxx) from the market in September 2004 by its manufacturer, Merck & Co., "raises many questions concerning drug policy, scientific evidence, and treatment alternatives.
Researchers at the University of South Florida (USF) College of Nursing have shown that brief treatments with Accelerated Resolution Therapy (ART) substantially reduce symptoms associated with post-traumatic stress disorder (PTSD) including, depression, anxiety, sleep dysfunction and other physical and psychological symptoms.
› Verified 7 days ago